By Dow Jones Business News,
January 15, 2014, 12:55:00 PM EDT
Jury Rules Medtronic Violated Patent
Medtronic Inc. said a federal court jury ruled the medical-device maker's CoreValve system infringed the Cribier
transcatheter heart valve patent of rival Edwards Lifesciences Corp.
Medtronic said it plans to appeal the decision.
Edwards Lifesciences was awarded more than $390 million in damages, but the jury verdict didn't impose any
Edwards said in a statement Wednesday that it will move to enforce the verdict and intends to seek a permanent
injunction. The company also said the jury's finding of willfulness in the case allows Edwards to seek increased damages
of up to three times that amount, in addition to attorneys' fees.
Medtronic said earlier Wednesday that if Edwards sought any injunctions, it planned to oppose the move.
Neil Ayotte, Medtronic vice president and acting general counsel, said in a statement, "While we are disappointed in
the jury's verdict, we continue to believe that this decision will be overturned on appeal."
"Medtronic has prevailed against Edwards in several legal actions related to a European counterpart to this patent and
others, and believes the Federal Circuit Court of Appeals will find no merit to Edward's infringement claim," Mr. Ayotte
Medtronic anticipates U.S. regulatory approval of the CoreValve System for extreme-risk patients by the end of its
current fiscal year, and intends to begin selling the device in the U.S. at that time.
The patent covered under the latest jury decision expires in December 2017, according to Edwards Lifesciences.
The company said that a federal jury in 2010 found that Medtronic's CoreValve willfully infringes on Edwards' Andersen
transcatheter heart-valve patent, with damages awarded to Edwards, a decision that was upheld on appeal.
A decision on Edwards' request to enjoin Medtronic's entrance to the U.S. market and for additional damages in the
Andersen patent case is pending. Because some of Medtronic's sales have been found to infringe both the Andersen and
Cribier patents, a portion of the damages awarded in the Cribier case could be reduced.
Write to Tess Stynes at email@example.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
(END) Dow Jones Newswires
Copyright (c) 2014 Dow Jones & Company, Inc.